Page 2 - Nasdaq Cbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catalyst Biosciences (NASDAQ:CBIO – Get Free Report) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.07) earnings per share for the quarter, hitting the consensus estimate of ($0.07), Yahoo Finance reports. Catalyst Biosciences Trading Up 18.4 % CBIO traded up $0.08 during trading hours on Thursday, hitting $0.52. The company’s stock had […]

Catalyst Biosciences (NASDAQ:CBIO – Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07), Yahoo Finance reports. Catalyst Biosciences Trading Up 18.4 % CBIO stock traded up $0.08 on Thursday, hitting $0.52. 481,593 shares of the company’s stock traded hands, compared […]

Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Free Report) saw a significant decline in short interest in July. As of July 31st, there was short interest totalling 46,600 shares, a decline of 83.3% from the July 15th total of 279,500 shares. Based on an average daily volume of 540,100 shares, the short-interest ratio is presently 0.1 […]

Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.26 and traded as high as $0.37. Catalyst Biosciences shares last traded at $0.35, with a volume of 145,309 shares trading hands. Catalyst Biosciences Trading Up 5.5 […]

Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) was the target of a large decline in short interest in May. As of May 31st, there was short interest totalling 251,800 shares, a decline of 21.9% from the May 15th total of 322,400 shares. Based on an average daily trading volume, of 226,900 shares, the short-interest ratio […]